FTC May Set Parameters Of Acceptable Brand/Generic Reverse Settlements

While the Federal Trade Commission is continuing its battle against reverse settlements, the agency concedes that not all deals are anticompetitive - and it would like to delineate which ones are acceptable

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet